Dis-chem revenue rose 9.4% to R17.9 billion in the 6 months to end August.

Loading player...
GUEST - GUEST - Rui Morais – Dis-Chem CEO

Pharmacy group Dis-Chem is growing revenue, profits are under pressure as it fights for market share in a tough economy. Group revenue rose 9.4% to R17.9 billion in the six months to end August, the group announced on Friday, or just over 10% when excluding the effect of Covid-19 vaccines in the prior period. But headline earnings fell about 17% to just under R500 million, with margins under pressure in personal care and beauty as the retailer picked up its promotional activity.
6 Nov 2023 3PM English South Africa Business News · Investing

Other recent episodes

Can You Trust AI for High-Stakes Decisions?

Should you rely on AI for critical legal or financial choices? My AI Lawyer Head of Services Michael Visser joins Nzinga Qunta to unpack how specialized AI acts as an affordable starting point to navigate your rights before paying for professional advice.
5 Nov 1PM 13 min

How to Invest in Banana Trees

Expanding beyond traditional livestock, crowdfarming is now giving everyday South Africans direct access to plant-based farm assets. Ntuthuko Shezi breaks down the mechanics of banana tree investments, harvest yield returns, and risk management for retail investors looking to grow real farm wealth.
5 Nov 1PM 15 min

FlySafair’s R7bn Deal Approved

Following the Competition Tribunal’s approval of Harith’s takeover of FlySafair, aviation analyst Guy Leitch joins KayBiz to unpack market concentration, cross-ownership with Lanseria Airport, and the impact on domestic ticket prices.
5 Nov 12PM 8 min

Reshaping Philanthropy

Operating globally, the Black Feminist Fund is challenging traditional donor models. We unpack how flexible core funding and participatory grantmaking shift capital and long-term institutional power directly to grassroots movements.
5 Nov 12PM 16 min